This study, called "T1D Pregnancy & Me," is looking for pregnant women with Type 1 Diabetes (T1D) to understand how diabetes is managed during pregnancy. It's an observational study, meaning you won't receive a new treatment, but researchers will collect real-world information about your diabetes management. Specifically, they're interested in how hybrid closed loop insulin delivery systems (a device that automatically adjusts insulin based on continuous glucose monitor (CGM) readings) are used. The main goal is to see how well blood glucose levels stay between 63-140 mg/dl up to 37 weeks of pregnancy. You can join if you are at least 18 years old, have had T1D for at least 6 months, are less than 15 weeks pregnant, and regularly use a CGM. The study is currently unclear on its recruitment status.

Study design

This is an observational study with a planned enrollment of 500 women. It aims to collect real-world data on diabetes management during pregnancy.

What's involved

You would complete online surveys and share data from your continuous glucose monitor (CGM) and insulin device. You would also need to continue using your CGM regularly throughout the study.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, CGM Outcome, is measured up to 37 weeks gestation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.